UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Inquiry Search clinical trials

Name
UMIN ID

Recruitment status Completed
Unique ID issued by UMIN UMIN000044175
Receipt No. R000050427
Scientific Title Effect of Daily Intake of Test Food on Intestinal Environment : A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study
Date of disclosure of the study information 2022/08/05
Last modified on 2022/04/05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effect of Daily Intake of Test Food on Intestinal Environment : A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study
Acronym Effect of Daily Intake of Test Food on Intestinal Environment
Scientific Title Effect of Daily Intake of Test Food on Intestinal Environment : A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study
Scientific Title:Acronym Effect of Daily Intake of Test Food on Intestinal Environment
Region
Japan

Condition
Condition Healthy Adult
Classification by specialty
Not applicable
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To prove the effect of test food on intestinal environment associated with 4 week daily intake in a randomized, double-blind, placebo-controlled, parallel group study.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Bowel diary at 4 weeks after beginning the intake of test food.
Key secondary outcomes Intestinal flora, gut metabolome, heart rate variability, sleeping record, electroencephalogram during sleeping, survey on subjects' sleeping and mental and physical conditions, blood metabolome, analysis of fecal samples, the Japanese version of constipation assessment scale MT version (CAS-MT), blood inflammatory marker.

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Cluster
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation NO
Institution consideration
Blocking
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 Daily ingestion 5 tablets of active test food for 4 weeks.
Interventions/Control_2 Daily ingestion 5 tablets of placebo test food for 4 weeks.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
65 years-old >
Gender Male and Female
Key inclusion criteria 1. Subjects who agree to participate in this study with a written informed consent.
2. Subjects with ailment on defecation.
Key exclusion criteria 1. Subjects with a clinical history of gastrointestinal cancer or currently under treatment or anti-tumor medication.
2. Subjects with gastrointestinal disorders.
3. Subjects who use gastrointestinal drugs or female hormone once or more a week.
4. Subjects with serious cerebrovascular, cardiac, hepatic, renal, gastrointestinal diseases, and/or affected with infectious diseases requiring reports to the authorities.
5. Subjects with major surgical history relevant to the digestive system.
6. Subjects with unusually high and/or low blood pressure and/or abnormal hematological data.
7. Subjects with severe anemia.
8. Pre- or post-menopausal women complaining of obvious physical changes.
9. Subjects who repeat constipation and diarrhea.
10. Subjects with defecation frequency 3 or less/ 9 or more per weeks.
11. Subjects with stool characteristics (Bristol scale) 5 or more.
12. Subjects who have habit to consume yogurt 6 days or more per week.
13. Subjects who have habit to consume beverages include lactic acid bacteria and/or bifidobacteria 2 days or more per week.
14. Subjects who have habit to consume beverages include dietary fiber reinforced food and/or oligo sugar 1 day or more per week.
15. Subjects who have allergy to drugs or foods especially based on soybean and yeast.
16. Subjects who used antibiotics within 12 weeks, prior to the current study.
17. Heavy smokers, alcohol addicts or subjects with disordered lifestyle.
18. Subjects who donated either 400 ml whole blood within 16 weeks (women), 12 weeks (men), 200 ml whole blood within 4 weeks, or blood components within 2 week, prior to the study.
19. Pregnant or lactating women or women who expect to be pregnant during this study.
20. Subjects who currently participate in other clinical trials, or participated within the last 4 weeks prior to the study.
21. Any other medical and/or health reasons unfavorable to participation in the current study, as judged by the principal investigator.
Target sample size 40

Research contact person
Name of lead principal investigator
1st name Naoyuki
Middle name
Last name HONMA
Organization Hokkaido Information University
Division name Department of Medical Management and Informatics
Zip code 069-8585
Address 59-2, Nishi-nopporo, Ebetsu, Hokkaido, 069-8585, Japan
TEL 011-385-4411
Email hisc-acad.res@s.do-johodai.ac.jp

Public contact
Name of contact person
1st name Naoyuki
Middle name
Last name HONMA
Organization Hokkaido Information University
Division name Health Information Science Center
Zip code 069-8585
Address 59-2, Nishi-nopporo, Ebetsu, Hokkaido, 069-8585, Japan
TEL 011-385-4430
Homepage URL
Email hisc-acad.res@s.do-johodai.ac.jp

Sponsor
Institute Hokkaido Information University
Institute
Department

Funding Source
Organization National Agriculture and Food Research Organization
Organization
Division
Category of Funding Organization Government offices of other countries
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor National Agriculture and Food Research Organization
National Institute of Advanced Industrial Science and Technology
Bioresource and Bioenvironment Kyushu University
Name of secondary funder(s) Asahi Quality & Innovations, Ltd.

IRB Contact (For public release)
Organization The ethics committee of Hokkaido Information University
Address 59-2, Nishi-nopporo, Ebetsu, Hokkaido, 069-8585, Japan
Tel 011-385-4411
Email soumu@do-johodai.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 北海道情報大学 保健センター(北海道)

Other administrative information
Date of disclosure of the study information
2022 Year 08 Month 05 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2021 Year 04 Month 28 Day
Date of IRB
2021 Year 04 Month 28 Day
Anticipated trial start date
2021 Year 06 Month 30 Day
Last follow-up date
2021 Year 09 Month 09 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2021 Year 05 Month 11 Day
Last modified on
2022 Year 04 Month 05 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050427

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.